Variant report

Variant	nsv968069
Chromosome Location	chr4:171381804-171396858
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CLCN3-10	chr4:171384331-171384509	l_2774_chr4:171384330-171431550_prostate

Extended variants
information (count: 134 )
Associated
traits (count: 68 )

Variant overlapped rSNPs/rCNVs (count:134 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs148781007	chr4:171384368-171384369	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
2	rs560985969	chr4:171384376-171384377	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
3	rs141519829	chr4:171384379-171384380	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
4	rs10001386	chr4:171384420-171384421	Inactive region	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs114681399	chr4:171384468-171384469	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
6	rs577337556	chr4:171384499-171384500	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
7	rs2698226	chr4:171385609-171385610	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs140394853	chr4:171385620-171385621	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs149965858	chr4:171385680-171385681	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs145083736	chr4:171385684-171385685	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs561910994	chr4:171385705-171385706	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs183582433	chr4:171385737-171385738	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs550233312	chr4:171385803-171385804	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs72988722	chr4:171385833-171385834	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs370109408	chr4:171385852-171385853	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs55875411	chr4:171385875-171385876	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs1534657	chr4:171385878-171385879	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs1534658	chr4:171385881-171385882	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs539005279	chr4:171385903-171385904	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs552836970	chr4:171385907-171385908	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs538425251	chr4:171385934-171385935	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs78821871	chr4:171385953-171385954	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs188466237	chr4:171385982-171385983	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs537795102	chr4:171385993-171385994	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs535314832	chr4:171386002-171386003	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs578129283	chr4:171386043-171386044	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs376837160	chr4:171386066-171386067	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs149098416	chr4:171386067-171386068	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs17055676	chr4:171386078-171386079	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs192845628	chr4:171386110-171386111	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs184219930	chr4:171386122-171386123	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs548230056	chr4:171386133-171386134	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs564502382	chr4:171386154-171386155	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs146090040	chr4:171386171-171386172	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs547469811	chr4:171386175-171386176	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs144730623	chr4:171386183-171386184	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs71622391	chr4:171386188-171386189	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs188112920	chr4:171386214-171386215	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs17055680	chr4:171386216-171386217	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs529018908	chr4:171386247-171386248	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs1534659	chr4:171386268-171386269	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
42	rs565545934	chr4:171386321-171386322	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs562195152	chr4:171386342-171386343	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs116807990	chr4:171386343-171386344	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs202083457	chr4:171386374-171386375	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs191424319	chr4:171386438-171386439	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs183948097	chr4:171386508-171386509	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs559200316	chr4:171386513-171386514	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs528813100	chr4:171386518-171386519	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs547247598	chr4:171386530-171386531	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:68)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
primary effusion lymphomas	17116491	CNVD
Breast cancer	16272173	CNVD
Breast cancer	17133270	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Olfactory neuroblastoma	18408657	CNVD
Breast cancer	21785460	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21633010	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20581869	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	17053054	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
abnormal development	18461090	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Neuroblastoma	16790693	CNVD
Developmental delay	22127048	CNVD
Autism	20808228	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:9 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:171385600-171387400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr4:171386000-171387000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr4:171386400-171386800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
4	chr4:171386600-171387400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
5	chr4:171386600-171387400	Enhancers	HMEC	breast
6	chr4:171386800-171387200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
7	chr4:171387000-171387400	Enhancers	ES-I3 Cell Line	embryonic stem cell
8	chr4:171387400-171388800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
9	chr4:171389000-171389200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links